| Literature DB >> 32945867 |
Christina L Faust1,2, Kirstyn Brunker1, Diana Ajambo3, Mary Ryan4, Arinaitwe Moses3, Candia Rowel3, Robert Mandela Wangoola5, Eddie M Wampande6, Andrew Guma3, Moses Adriko3, Poppy H L Lamberton1,2, Edridah M Tukahebwa3, Albert Mugenyi5, Charles Waiswa5.
Abstract
Improvements in genetic and genomic technology have enabled field-deployable molecular laboratories and these have been deployed in a variety of epidemics that capture headlines. In this editorial, we highlight the importance of building physical and personnel capacity in low and middle income countries to deploy these technologies to improve diagnostics, understand transmission dynamics and provide feedback to endemic communities on actionable timelines. We describe our experiences with molecular field research on schistosomiasis, trypanosomiasis and rabies and urge the wider tropical medicine community to embrace these methods and help build capacity to benefit communities affected by endemic infectious diseases.Entities:
Mesh:
Year: 2021 PMID: 32945867 PMCID: PMC7788292 DOI: 10.1093/trstmh/traa086
Source DB: PubMed Journal: Trans R Soc Trop Med Hyg ISSN: 0035-9203 Impact factor: 2.184